Nasdaq IPOs

CS Disco, which provides software for ediscovery, legal document review, and case management, announced terms for its IPO on Monday. The Austin, TX-based company plans to raise $193 million by offering 7 million shares at a price range of $26 to $29. At the midpoint of the propo

Zevia PBC, which makes zero calorie soft drinks sweetened with stevia, announced terms for its IPO on Monday. The Encino, CA-based company plans to raise $200 million by offering 14.3 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Zevia PBC

Paycor HCM, which provides a SaaS human capital management platform for SMBs, announced terms for its IPO on Monday.The Cincinnati, OH-based company plans to raise $361 million by offering 18.5 million shares at a price range of $18 to $21. New investors Neuberger Berman, ClearBr

Kaltura, which provides live and on-demand video SaaS solutions, announced terms for its IPO on Monday. The New York, NY-based company plans to raise $150 million by offering 15 million shares at a price range of $9 to $11. At the midpoint of the proposed range, Kaltura woul

Dynacure, a French Phase 1/2 biotech developing therapies for neuromuscular diseases, announced terms for its IPO on Monday. The Illkirch-Graffenstaden, France-based company plans to raise $100 million by offering 6.3 million ADSs at a price range of $15 to $17. At the midpoint

Erasca, a Phase 2 biotech developing therapies for RAS/MAPK pathway-driven cancers, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $263 million by offering 17.5 million shares at a price range of $14 to $16. At the midpoint of the proposed

Perspectum Group, which provides a portfolio of medical imaging software, announced terms for its IPO on Monday.The Oxfordshire, United Kingdom-based company plans to raise $75 million by offering 4.7 million ADSs at a price range of $15 to $17. At the midpoint of the proposed ra

Perspectum Group, which provides a portfolio of medical imaging software, announced terms for its IPO on Monday.The Oxfordshire, United Kingdom-based company plans to raise $75 million by offering 4.7 million ADSs at a price range of $15 to $17. At the midpoint of the proposed ra

Couchbase, which provides NoSQL database technology for application developers, announced terms for its IPO on Monday. The Santa Clara, CA-based company plans to raise $151 million by offering 7 million shares at a price range of $20 to $23. At the midpoint of the proposed range

Imago BioSciences, a Phase 2 biotech developing small molecules for bone marrow cancer and diseases, announced terms for its IPO on Monday.The South San Francisco, CA-based company plans to raise $105 million by offering 7 million shares at a price range of $14 to $16. The compan

Rapid Micro Biosystems, which provides an automated microbial testing device and platform, announced terms for its IPO on Monday. The Lowell, MA-based company plans to raise $125 million by offering 6.6 million shares at a price range of $18 to $20. At the midpoint of the propos

TScan Therapeutics, a preclinical biotech developing engineered T cell cancer therapies, announced terms for its IPO on Monday.The Waltham, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed

Blue Whale Acquisition I, a blank check company formed by Mubadala Capital targeting media and entertainment, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The Cayman Islands-based company plans to raise $200 million by offering 20 milli

After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million.  Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to raise $25 million at a $54 million market ca

Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, filed on Friday with the SEC to raise up to $100 million.The company's multi-modality drug discovery platform targets both genetic and non-genetic forms of heart disease, and consists

AfterNext HealthTech Acquisition, a blank check company backed by TPG targeting healthcare technology, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Fort Worth, TX-based company plans to raise $300 million by offering 30 million unit

After a slow holiday week, nine IPOs are scheduled to raise over $3 billion in the week ahead. Italian drug container supplier Stevanato Group (STVN) plans to raise $900 million at a $6.8 billion market cap. Controlled by its founding family, the profitable company supplies glas

Activate Permanent Capital, a blank check company targeting sustainability, filed on Friday with the SEC to raise up to $250 million in an initial public offering. The San Francisco, CA-based company plans to raise $250 million by offering 25 million units at $10 per unit. Each

Rani Therapeutics, which develops ingestible capsules for oral dosing of medication, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Rani Therapeutics is a clinical stage biotherapeutics company advancing technologies to enable the developm

Nalu Medical, which is commercializing a nerve stimulation implant for chronic neuropathic pain, filed on Friday with the SEC to raise up to $100 million.Nalu states that its miniaturized implantable pulse generator (IPG) delivers gentle electrical pulses to the nervous system to